FOXO4-DRILongevity

Senolytic peptide studied for clearing senescent cells.

Peptides·Index rating

2/5Early-Signal

Human data

Safety

Compare prices — from $130.00

Quick factsat a glance

Status: Research / not approved
Developer: —
Receptors / target: —
FDA-approved?: NO
Prescription available?: NO
Studied for: —

Similar compounds

NAD+LongevityCoenzyme studied for cellular energy and longevity.EpitalonLongevityTelomerase peptide studied for sleep and aging.MOTS-cLongevityMitochondrial peptide studied for metabolism and endurance.VilonLongevityKhavinson dipeptide bioregulator studied for immune support.

For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.